The spray, called Spravato, is now the first-ever standalone therapy for treatment-resistant depression, which is when trying at least two standard treatments does little to nothing to improve depression symptoms in a patient.
Were the people who work on the business side of healthcare to more consistently (and loudly) anchor ourselves to the simple ethics that drew us to healthcare in the first place—"I want to contribute to society"—we might just begin to see ourselves less as helpless, hopeless objects of the system and instead as the drivers of the system.
Public health experts say U.S. withdrawal from the W.H.O. would undermine the nation's standing as a global health leader and make it harder to fight the next pandemic.
President Donald Trump, in the executive order, said: "The previous administration has embedded deeply unpopular, inflationary, illegal and radical practices within every agency and office of the federal government. The revocations within this order will be the first of many steps the United States federal government will take to repair our institutions and our economy."
President Trump began his second term Monday with a sweeping order aimed at reversing dozens of former President Biden's top priorities, from regulations aimed at lowering healthcare costs, to coronavirus outreach, Affordable Care Act expansions, and protections against gender-based discrimination.
A VA study on the relationship between GLP-1 weight-loss drugs and 175 diseases and conditions supports a lot of what scientists already suspected about potential benefits, but contains a few surprises, too. The findings, published Monday in the journal Nature Medicine and based on an analysis of medical records from about 2.5 million patients in the VA system, support the idea that the medications might be able to help patients with Alzheimer’s disease and who are suffering from substance abuse involving alcohol, cannabis and narcotics.